Answers are grounded in this paper and cite their sources.
Background Atherogenic dyslipidemia and central adiposity are two interrelated metabolic features implicated in the development and progression of cardiometabolic multimorbidity (CMM). This study investigated the separate and combined associations of the atherogenic index of plasma (AIP) and waist-to-height ratio (WHtR) with incident CMM. Methods This prospective cohort study included 8,680 participants from the China Health and Retirement Longitudinal Study (CHARLS) who were free of CMM at baseline and were followed from 2011 to 2020. CMM was ascertained using self-reported physician diagnoses. Multivariable Cox proportional hazards models were used to evaluate the separate and combined associations of AIP and WHtR with incident CMM. Blood-sample-weighted Cox and Fine–Gray models were co-primary analyses. Restricted cubic splines were used to examine dose–response relationships, and multiplicative interactions between AIP and WHtR were assessed. Missing covariates were handled using multiple imputation, and the incremental predictive value of adding AIP and WHtR to the conventional risk model was further evaluated. Results During a median follow-up of 9 years, 951 participants developed incident CMM. In Model III, high AIP and high WHtR were separately associated with higher risks of CMM, with HRs of 1.50 (95% CI 1.30–1.74) and 2.00 (95% CI 1.65–2.42), respectively. Compared with participants with low AIP and low WHtR, those with concurrent high AIP and high WHtR had a higher hazard of incident CMM (HR 2.61, 95% CI 2.05–3.33). Weighted and competing-risk analyses yielded similar estimates. Adding AIP and WHtR to the base model resulted in a small increase in the AUC from 0.753 to 0.773 (ΔAUC 0.020, 95% CI 0.0107–0.0297); the corresponding optimism-corrected AUCs were 0.748 and 0.768. Conclusions Higher AIP and WHtR were separately and in combination associated with incident CMM among middle-aged and older Chinese adults. Concurrent elevation of both markers identified a higher-risk lipid–adiposity phenotype. Combined assessment of AIP and WHtR showed modest, hypothesis-generating incremental predictive value and requires external validation before clinical use.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: